Details for 2019732781

Up to date per 03.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON HÄMOPHILIE A

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019732781

EP Publication Number

3793588

E-Number

1778399

Language

PCT Number

US19032956

Publication Date

24.03.2021 A

26.03.2025 B1

Registration Date

26.03.2025

AT Publication Date

15.04.2025

Application Date

17.05.2019

Registration Number

Priorities

18.05.2018

201862673670 P

31.07.2018

201862712880 P

30.11.2018

201862773785 P

05.02.2019

201962801576 P

IPC

A61K 38/36 20060101AFI20191122BHEP

Maximum Duration of Protection

17.05.2039

Owner

Bioverativ Therapeutics Inc.225 Second Avenue Waltham MA 02451US

Representative

No representatives present

Inventor

INNES, Alisonc/o Bioverativ Therapeutics Inc. 225 Second Avenue Waltham, Massachusetts 02451US

KATRAGADDA, Sureshc/o Bioverativ Therapeutics Inc. 225 Second Avenue Waltham, Massachusetts 02451US

RICE, Karac/o Bioverativ Therapeutics Inc. 225 Second Avenue Waltham, Massachusetts 02451US

RUDIN, Danc/o Bioverativ Therapeutics Inc. 225 Second Avenue Waltham, Massachusetts 02451US

SETH CHHABRA, Ekta44 Hundreds Road Westborough, MA 01581US

WONG, Nancyc/o Bioverativ Therapeutics Inc. 225 Second Avenue Waltham, Massachusetts 02451US

Information about Fees